Abstract
Background: A52 year old female who was diagnosed as Young Onset Parkinson's Disease (YOPD) at the age of 31 years, developed severe L-dopa induced dyskinesias. She had been taking Amantadine 200 mg/day since the past 12 years, later the dose had been increased to 300mg/day. After three months, the patient complained of visual symptoms, and had developed a painless, progressive and bilateral corneal edema. The patient could not afford DBS as an alternative to these medications. Ultimately, Amantidine was stopped, and post cessation of the drug, the dyskinesias worsened.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
